Abstract:Objective: To explore the effects of dezocine (Dez) on the proliferation, apoptosis, and epithelial-mesenchymal transition of uterine corpus endometrial cancer (UCEC) cells by regulating p38 mitogen-activated protein kinase 38 (p38MAPK)/c-Jun N-terminal kinase (JNK) signaling pathway. Methods: Human UCEC cells HEC-1A were cultured in vitro and randomly assigned into NC group, low-dose Dez group, medium-dose Dez group, high-dose Dez group (2.5, 5, 10μg/mL Dez), and high-dose Dez+SB203580 group (10μg/mL Dez+10μmol/L p38MAPK inhibitor SB203580). MTS method was used to detect the proliferation of HEC-1A cells. The plate cloning method was used to measure the clonogenic ability of HEC-1A cells. Flow cytometry was used to measure apoptosis of HEC-1A cells. Transwell experiment was used to detect the invasion of HEC-1A cells. Western blot was used to measure the E-cadherin, N-cadherin, Snail, and p38MAPK/JNK signaling pathway proteins. Results: For the NC group, the low-dose, medium-dose, and high-dose Dez groups showed a decrease in D(λ)490nm, colony formation rate, cell invasion number, N-cadherin, and Snail proteins in HEC-1A cells, and an increase in apoptosis rate, E-cadherin, p-p38MAPK/p38MAPK, and p-JNK/JNK proteins (P<0.05). For the high-dose Dez group, the high-dose Dez+SB203580 group showed an increase in D(λ)490nm, colony formation rate, cell invasion number, N-cadherin, and Snail proteins in HEC-1A cells, and a decrease in apoptosis rate, E-cadherin, p-p38MAPK/p38MAPK, and p-JNK/JNK proteins (P<0.05). Conclusion: Dez exerts inhibitory effects on the proliferation, invasion, and epithelial mesenchymal transition of UCEC cells, while promoting UCEC cells apoptosis. This is likely mediated through activating the p38MAPK/JNK signaling pathway.
李传进, 曹晓霞, 丁章俊. 地佐辛调节p38MAPK/JNK信号通路对子宫内膜癌细胞增殖侵袭凋亡等影响[J]. 河北医学, 2025, 31(12): 1943-1949.
LI Chuanjin, CAO Xiaoxia, DING Zhangjun. Effect of Dezocine on the Proliferation Invasion and Apoptosis of Endometrial Carcinoma Cells via Regulating p38MAPK/JNK Signaling Pathway. HeBei Med, 2025, 31(12): 1943-1949.
[1] Crosbie EJ,Kitson SJ,McAlpine JN,et al.Endometrial cancer[J].Lancet,2022,399(10333):1412-1428. [2] Huang Y,Wang Y,Wang Y,et al.LPCAT1 promotes cutaneous squamous cell carcinoma via EGFR-mediated protein kinase B/p38MAPK signaling pathways[J].Invest Dermatol,2022,142(2):303-313. [3] Donohoe F,Wilkinson M,Baxter E,et al.Mitogen-activated protein kinase (MAPK) and obesity-related cancer[J].Int Mol Sci,2020,21(4):1241. [4] Chen H,Wang M,Zhang Z,et al.Oxidative stress drives endometrial fibrosis via TGF-β1/MAPK signaling pathway in breast cancer[J].FASEB,2024,38(22):70172. [5] Zhang C,Pan R,Ma S,et al.Dezocine inhibits cell proliferation,migration,and invasion by targeting CRABP2 in ovarian cancer[J].Open Med (Wars),2022,17(1):2052-2061. [6] 张广蒙,马玉峰,李凤利,等.地佐辛调节PI3K/AKT/GSK-3β信号通路对卵巢癌细胞恶性生物学行为的影响[J].中国优生与遗传杂志,2023,31(5):940-945. [7] 刘莹莹.蓝萼乙素通过JNK和p38 MAPK通路诱导人宫颈癌细胞凋亡和细胞周期阻滞[D].新乡医学院,2019. [8] 中国抗癌协会妇科肿瘤专业委员会.子宫内膜癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):501-512. [9] Ye RR,Jiang S,Xu X,et al.Dezocine as a potent analgesic:overview of its pharmacological characterization[J].Acta Pharmacol Sin,2022,43(7):1646-1657. [10] Xue C,Chen W,Yuan A,et al.Dezocine,an opioid analgesic,exerts antitumor effects in triple-negative breast cancer by targeting nicotinamide phosphoribosyltransferase[J].Front Pharmacol,2021(12):600296. [11] Wang H,Chiang C,Xue C,et al.Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway[J].Toxicol Res (Camb),2022,11(3):498-510. [12] Optawski M,Nowakowski R,Srednicka A,et al.Molecular landscape of the epithelial-mesenchymal transition in endometrioid endometrial cancer[J].Clin Med,2021,10(7):1520. [13] 叶晶,李萍,赵金荣,等.五味子酯乙靶向PTGS1抑制子宫内膜癌细胞增殖和上皮间质转化[J].医学分子生物学杂志,2025,22(1):23-28. [14] Man GCW,Wang J,Song Y,et al.Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer[J].BMC Cancer,2020,20(1):964. [15] Liang X,Ju J.Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK[J].Oncol Rep,2021,45(5):82.